?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Aktien Screener
Filter & Suche
187 Ergebnisse (2 aktive Filter)
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
Suchergebnisse
187 Unternehmen gefunden • Seite 5 von 8
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Twist Bioscience Corp | 28.9 | Arzneimittel (Biotechnologie) | USA | 8.4 Mrd. USD | - | - | 19.53 | 18.92 | ▲ 33.11% | ▼ -11.11% | - | - | - | -20.63% | ▲ 22.90% | -36.18% | ▲ 21.02% | -20.08% | ▲ 25.94% | 5 / 9 | −2,10 | −14.369,1-fach | 30 / 100 | −4,7 / 100 | −2,14 |
 | Arbutus Biopharma Corp | 28.7 | Arzneimittel (Biotechnologie) | USA | 1.0 Mrd. USD | 6.63 | - | 5.58 | 3.92 | ▲ 15.29% | ▼ -12.07% | - | - | - | -237.88% | ▼ -4.30% | -192.08% | ▼ -11.49% | -281.45% | ▼ -28.09% | 4 / 9 | −39,33 | −253,4-fach | 14 / 100 | 6,5 / 100 | 0,28 |
 | Aktis Oncology, Inc. Common stock | 28.6 | Arzneimittel (Biotechnologie) | USA | 1.3 Mrd. USD | - | - | 128.82 | 2.67 | ▲ 35.11% | ▲ 15.59% | - | - | - | -980.93% | ▲ 3.24% | -1149.52% | ▼ -182.52% | -1134.54% | ▲ 249.85% | 3 / 9 | 1,01 | −26,4-fach | 2 / 100 | 0,2 / 100 | −0,20 |
 | CG Oncology, Inc. Common stock | 28.4 | Arzneimittel (Biotechnologie) | USA | 6.4 Mrd. USD | - | - | 1029.73 | 6.23 | - | - | - | - | - | -3985.02% | ▲ 310.49% | -4722.13% | ▼ -81.47% | -3279.21% | ▲ 238.74% | 4 / 9 | 23,38 | −42,1-fach | −0 / 100 | −3,6 / 100 | 2,50 |
 | Dianthus Therapeutics Inc. | 28.2 | Arzneimittel (Biotechnologie) | USA | 5.8 Mrd. USD | - | - | 3049.14 | 4.95 | - | - | - | - | - | -7973.33% | ▼ -1508.94% | -8739.34% | ▼ -1687.63% | -6349.36% | ▼ -526.13% | 3 / 9 | 14,36 | - | 0 / 100 | −6,3 / 100 | −4,59 |
 | Ideaya Biosciences Inc | 27.9 | Arzneimittel (Biotechnologie) | USA | 3.6 Mrd. USD | - | - | 15.49 | 3.03 | ▲ 62.11% | ▲ 28.65% | - | - | - | -51.99% | ▼ -357.72% | -72.84% | ▼ -433.42% | -33.59% | ▼ -306.31% | 4 / 9 | 13,17 | −22,3-fach | −9 / 100 | −3,8 / 100 | 13,72 |
 | Immunitybio Inc | 27.8 | Arzneimittel (Biotechnologie) | USA | 8.4 Mrd. USD | - | - | 50.57 | -8.01 | ▲ 184.76% | ▲ 22.18% | - | - | - | -310.18% | ▲ 24440.35% | -226.00% | ▲ 21431.17% | -272.56% | ▲ 23590.01% | 4 / 9 | −24,62 | −2,5-fach | 22 / 100 | −9,3 / 100 | 4,30 |
 | Insmed Inc | 27.8 | Arzneimittel (Biotechnologie) | USA | 28.3 Mrd. USD | - | - | 24.84 | 37.31 | ▲ 29.83% | ▲ 34.13% | - | - | - | -210.54% | ▼ -1.48% | -194.04% | ▼ -4.51% | -159.55% | ▲ 4.73% | 5 / 9 | −7,29 | −10,7-fach | 21 / 100 | −15,1 / 100 | −2,16 |
 | Axsome Therapeutics Inc | 27.6 | Arzneimittel (Pharmazeutisch) | USA | 11.6 Mrd. USD | - | - | 14.89 | 138.81 | - | - | - | - | - | -28.69% | ▲ 319.92% | -26.51% | ▲ 306.15% | -14.70% | ▲ 263.26% | 5 / 9 | −5,75 | −35,2-fach | 86 / 100 | −13,0 / 100 | −2,65 |
 | Aclaris Therapeutics Inc | 27.5 | Arzneimittel (Pharmazeutisch) | USA | 0.8 Mrd. USD | - | - | 95.28 | 6.29 | ▲ 3.84% | ▲ 4.94% | - | - | - | -829.58% | ▲ 61.54% | -975.91% | ▲ 24.61% | -603.42% | ▲ 46.57% | 4 / 9 | −15,48 | - | 4 / 100 | −11,1 / 100 | 4,20 |
 | Iovance Biotherapeutics Inc | 27.5 | Arzneimittel (Biotechnologie) | USA | 3.9 Mrd. USD | - | - | 11.99 | 5.29 | - | - | - | - | - | -148.38% | - | -153.08% | - | -127.61% | - | 5 / 9 | −7,20 | - | 28 / 100 | −9,7 / 100 | −3,21 |
 | Editas Medicine Inc | 27.3 | Arzneimittel (Biotechnologie) | USA | 0.4 Mrd. USD | - | - | 8.82 | 3.94 | ▼ -14.89% | ▲ 7.91% | - | - | - | -395.01% | ▲ 96.23% | -245.15% | ▲ 139.10% | -409.30% | ▲ 76.89% | 4 / 9 | −29,69 | −64,8-fach | 22 / 100 | 2,8 / 100 | −5,52 |
 | Ocular Therapeutix Inc | 27.3 | Arzneimittel (Pharmazeutisch) | USA | 2.3 Mrd. USD | - | - | 44.26 | 4.43 | ▲ 24.39% | ▲ 11.31% | - | - | - | -513.17% | ▼ -116.19% | -521.04% | ▼ -80.03% | -418.53% | ▼ -62.07% | 4 / 9 | 3,62 | −13,7-fach | 6 / 100 | −7,6 / 100 | −2,92 |
 | Arcus Biosciences Inc | 27.1 | Arzneimittel (Biotechnologie) | USA | 3.1 Mrd. USD | - | - | 26.76 | 6.75 | ▲ 25.93% | ▲ 23.50% | - | - | - | -142.91% | ▼ -18.48% | -156.28% | ▼ -21.87% | -195.95% | ▼ -69.84% | 1 / 9 | −0,51 | −65,9-fach | 21 / 100 | 11,3 / 100 | −2,26 |
 | Nektar Therapeutics | 27.1 | Arzneimittel (Pharmazeutisch) | USA | 2.4 Mrd. USD | - | - | 43.63 | 2.64 | ▼ -18.43% | ▼ -18.07% | - | - | - | -297.07% | ▲ 71.30% | -236.77% | ▲ 55.61% | -377.83% | ▲ 24.00% | 3 / 9 | −41,55 | −6,0-fach | 20 / 100 | 15,9 / 100 | −1,69 |
 | Agios Pharm | 26.9 | Arzneimittel (Biotechnologie) | USA | 2.0 Mrd. USD | - | - | 20.40 | 1.96 | ▼ -23.27% | ▲ 4.75% | - | - | - | -764.01% | ▼ -774861.58% | -873.87% | ▲ 182752.68% | -698.33% | ▲ 199476.83% | 3 / 9 | 12,83 | - | 3 / 100 | −3,1 / 100 | −1,68 |
 | Celldex Therapeutics Inc | 26.9 | Arzneimittel (Biotechnologie) | USA | 2.9 Mrd. USD | - | - | 25872.68 | 4.06 | ▼ -27.36% | ▲ 34.05% | - | - | - | -17253.33% | ▼ -2895.78% | -19160.00% | ▼ -3314.63% | -14243.93% | ▼ -2361.13% | 4 / 9 | 2,23 | - | 0 / 100 | −8,2 / 100 | 0,75 |
 | Sutro Biopharma | 26.7 | Arzneimittel (Biotechnologie) | USA | 0.3 Mrd. USD | - | - | 6.12 | -2.71 | ▲ 19.12% | ▲ 42.85% | - | - | - | -186.45% | ▼ -22.25% | -102.41% | ▼ -8.05% | -174.59% | ▼ -34.30% | 4 / 9 | −21,85 | −4,4-fach | 55 / 100 | −8,0 / 100 | −3,26 |
 | ARS Pharmaceuticals, Inc | 26.6 | Arzneimittel (Biotechnologie) | USA | 0.5 Mrd. USD | - | - | 4.05 | 37.83 | ▲ 36.42% | ▲ 176.24% | - | - | - | -203.25% | ▲ 297.32% | -212.92% | ▲ 297.61% | -203.14% | ▲ 330.87% | 3 / 9 | −0,91 | −82,7-fach | 19 / 100 | −0,1 / 100 | −0,62 |
 | Supernus Pharmaceuticals Inc | 26.6 | Arzneimittel (Pharmazeutisch) | USA | 2.4 Mrd. USD | - | 128.93 | 2.92 | 2.35 | ▲ 6.68% | - | - | - | - | -5.36% | ▼ -2.71% | -5.13% | ▼ -3.45% | 6.40% | ▼ -2.19% | 5 / 9 | 5,17 | 22-fach | 44 / 100 | −5,9 / 100 | −2,43 |
 | Sarepta Therapeutics Inc | 26.4 | Arzneimittel (Biotechnologie) | USA | 2.2 Mrd. USD | - | - | 1.09 | 1.41 | ▲ 32.41% | ▲ 5.18% | - | - | - | -32.45% | ▲ 14.22% | -29.92% | ▲ 14.01% | -13.99% | ▲ 12.91% | 3 / 9 | −2,77 | −18,2-fach | 39 / 100 | −15,2 / 100 | −3,35 |
 | Stoke Therapeutics Inc | 26.1 | Arzneimittel (Biotechnologie) | USA | 1.9 Mrd. USD | - | - | 67.90 | 5.42 | - | - | - | - | - | -3.73% | ▲ 614.71% | -11.16% | ▲ 627.93% | 24.35% | ▲ 463.98% | 5 / 9 | 5,51 | −7,9-fach | 44 / 100 | −12,5 / 100 | 2,33 |
 | Recursion Pharmaceuticals Inc | 26.0 | Arzneimittel (Biotechnologie) | USA | 1.7 Mrd. USD | - | - | 31.28 | 1.88 | ▲ 85.36% | ▲ 49.27% | - | - | - | -863.35% | ▲ 165.01% | -867.87% | ▲ 172.49% | -506.52% | ▲ 262.61% | 4 / 9 | −1,10 | −413,4-fach | −3 / 100 | −18,5 / 100 | −3,63 |
 | Taysha Gene Therapies Inc | 25.9 | Arzneimittel (Biotechnologie) | USA | 1.6 Mrd. USD | - | - | 167.37 | 6.62 | - | - | - | - | - | -1115.27% | - | -1130.65% | - | -960.07% | - | 4 / 9 | −0,50 | −59,0-fach | 3 / 100 | −4,6 / 100 | - |
 | Alector Inc | 25.8 | Arzneimittel (Biotechnologie) | USA | 0.2 Mrd. USD | - | - | 17.24 | -23.97 | ▼ -0.05% | ▼ -4.82% | - | - | - | -679.16% | ▼ -134.99% | -692.83% | ▼ -139.06% | -874.66% | ▼ -224.61% | 3 / 9 | −9,55 | - | 4 / 100 | 14,0 / 100 | - |
USA